论文部分内容阅读
目的:分析受血者输血前检测传染病血清5项指标的意义。方法:以2012年10月-2014年10月笔者所在医院收治的需行输血治疗的300例住院患者为研究对象,所有患者输血前均接受传染病血清5项指标(HBs Ag、抗-HCV、抗-HIV、梅毒、ALT)检测,观察各指标检测结果。结果:300例受血者输血前5项指标检测总阳性率23.00%,其中HBs Ag阳性率10.70%,ALT阳性率7.00%,HBs Ag+ALT双阳性率1.67%,HBsAg~+抗-HCV双阳性率0.33%,HBs Ag+梅毒双阳性率0.33%。另外,女性HBs Ag阳性率、5项指标总单阳性率分别为5.83%、14.17%,与男性的13.89%、23.89%比较,差异均有统计学意义(P<0.05)。结论:受血者输血前行血液传染病5项指标检测可确定患者是否患有输血相关传染性疾病,有效预防或减少因输血引发的医疗纠纷。
OBJECTIVE: To analyze the significance of five indicators of infectious sera before blood transfusion in recipients. Methods: A total of 300 hospitalized patients undergoing transfusion in our hospital from October 2012 to October 2014 were enrolled in this study. All patients received 5 serum markers of infectious diseases before transfusion (HBs Ag, anti-HCV, Anti-HIV, syphilis, ALT) test to observe the results of each index test. Results: The positive rate of HBs Ag was 10.70%, the positive rate of ALT was 7.00%, the double positive rate of HBs Ag + ALT was 1.67%, and the positive rate of HBsAg ~ + anti-HCV double positive The rate of 0.33%, HBsAg + syphilis double positive rate of 0.33%. In addition, the positive rate of HBsAg in women and the total single-positive rate of 5 indicators were 5.83% and 14.17%, respectively, which were significantly different from those of males (13.89% and 23.89%, P <0.05). Conclusion: The blood transfusion of blood transfusion 5 indicators before testing to determine whether patients with transfusion-related infectious diseases, effectively prevent or reduce the medical disputes caused by blood transfusion.